Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.

Gleneagles Hospital Hong Kong took part in Ageing Well Hong Kong 2026, bringing together professionals from across sectors to discuss solutions for the challenges and opportunities presented by an ageing population.
Dr Vince Lau, Director of the Interventional Radiology Centre and Consultant in Radiology, presented the latest developments in Histotripsy, a non-invasive cancer treatment. He shared Hong Kong’s clinical experience and case studies, while also highlighting ongoing clinical trials exploring the technology’s potential in treating pancreatic and kidney tumours.
Dr Lau emphasised the importance of tailoring treatment plans to each patient’s needs. By considering factors such as tumour location, liver function and overall health, healthcare teams can combine different treatment approaches to balance disease control, treatment costs and quality of life while expanding treatment options for suitable patients.
Joyce Smith, Regional Chief Commercial Officer of IHH Healthcare North Asia and Chief Commercial Officer of Gleneagles Hospital Hong Kong, also joined a panel discussion. She shared how private healthcare providers are supporting healthier ageing through prevention, early detection and efforts to improve the accessibility, transparency and predictability of healthcare services.
As healthcare needs continue to evolve, Gleneagles Hospital Hong Kong remains committed to combining clinical expertise, healthcare innovation and multidisciplinary collaboration to deliver more personalised, sustainable care for the communities it serves.